Lantheus Holdings, Inc. (LNTH): Price and Financial Metrics

LNTH POWR Grades

• Growth is the dimension where LNTH ranks best; there it ranks ahead of 93.26% of US stocks.
• LNTH's strongest trending metric is Quality; it's been moving up over the last 179 days.
• LNTH's current lowest rank is in the Stability metric (where it is better than 18.93% of US stocks).

LNTH Stock Summary

• LNTH's current price/earnings ratio is 39.16, which is higher than 84.15% of US stocks with positive earnings.
• Over the past twelve months, LNTH has reported earnings growth of -703.78%, putting it ahead of only 2.55% of US stocks in our set.
• Revenue growth over the past 12 months for LANTHEUS HOLDINGS INC comes in at 105.61%, a number that bests 92.14% of the US stocks we're tracking.
• Stocks that are quantitatively similar to LNTH, based on their financial statements, market capitalization, and price volatility, are SSTK, TECH, APPS, OSIS, and ZIP.
• Visit LNTH's SEC page to see the company's official filings. To visit the company's web site, go to www.lantheus.com.

LNTH Valuation Summary

• LNTH's price/sales ratio is 5; this is 150% higher than that of the median Healthcare stock.
• Over the past 90 months, LNTH's price/earnings ratio has gone up 87.8.

Below are key valuation metrics over time for LNTH.

LNTH Growth Metrics

Its 5 year revenue growth rate is now at 16.46%.
• Its 4 year cash and equivalents growth rate is now at 87.02%.
• The year over year revenue growth rate now stands at 58.72%.

LNTH's revenue has moved up $472,072,000 over the prior 52 months.

The table below shows LNTH's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	801.457	190.318	107.037
2022-06-30	664.238	101.09	32.39
2022-03-31	541.579	54.362	-37.325
2021-12-31	425.208	53.916	-71.279
2021-09-30	389.798	40.596	-34.476
2021-06-30	376.269	44.831	-27.447

LNTH's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• LNTH has a Quality Grade of C, ranking ahead of 29.96% of graded US stocks.
• LNTH's asset turnover comes in at 0.436 -- ranking 105th of 682 Pharmaceutical Products stocks.
• AVDL, OTIC, and SYRS are the stocks whose asset turnover ratios are most correlated with LNTH.

The table below shows LNTH's key quality metrics over time.